Skip to main content
SpringerLink
Log in

D

  • Chapter
Therapielexikon Neurologie

  • 1407 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 34.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Rebeiz JJ, Kolodny EH, Richardson EP (1968). Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 18: 20–33.

    PubMed  CAS  Google Scholar 

Literatur

  1. Martini R, Zielasek J, Toyka KV (1998) Inherited demyelinating neuropathies: from Gene to disease. Curr Opin Neurol 11: 545–556.

    PubMed  CAS  Google Scholar 

Literatur

  1. Stoppe G, Brandt CA, Staedt JM (1999). Behavioural problems associated with dementia: the role of newer antipsychotics. Drugs-Aging 14(1):41–54.

    PubMed  CAS  Google Scholar 

  2. Lebert F, Pasquier F, Souliez L, Petit H (1998). Tacrine efficacy in Lewy-body-dementia. Int-J-Geriatr-Psychiatry. 13(8):516–519.

    PubMed  CAS  Google Scholar 

Literatur

  1. Forette F; Seux ML; Staessen JA; Thijs L; Birkenhäger WH; Babarskiene MR; Babeanu S; Bossini A; Gil Extremera B; Girerd X; Laks T; Lilov E; Moisseyev V; Tuomilehto J; Vanhanen H; Webster J; Yodfat Y; Fagard R (1998). Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet Oct; 352:9137,1347–1351.

    Google Scholar 

Literatur

  1. Créange A, Meyrignac C, Roualdes B, Degos J-D, Gherardi RK (1995) Diphtheric neuropathy. Muscle Nerve 18: 1460–1463.

    PubMed  Google Scholar 

  2. Prospero E, Raffo M, Bagnoli M, Appignanesi R, D’Errico MM (1997) Diphtheria: epidemiological update and review of prevention and control strategies. Eur J Epidemiol 13: 527–534.

    Article  PubMed  CAS  Google Scholar 

  3. Sommer N, Winer JB (1996) Inflammatory and Infectious Polyneuropathy. In: Brandt T, Caplan LR, Dichgans J, Diener HC, Kennard C (eds) Neurological disorders. Course and treatment. Academic Press, San Diego, pp 873–890.

    Google Scholar 

Literatur

  1. Brown RD Jr, Wiebers DO, Nichols DA (1994). Intracranial dural arteriovenous fistulae: angiographic predictors of intracranial hemorrhage and clinical outcome in nonsurgical patients. J Neurosurg Oct; 81(4):531–8.

    Google Scholar 

Literatur

  1. Bendszus M, Warmuth-Metz M, Burger R et al. (2001) Diagnosing dural metastases: the value of 1H magnetic resonance spectroscopy. Neuroradiology 43:285–89.

    PubMed  CAS  Google Scholar 

  2. Kleinschmidt-DeMasters BK (2001). Dural metastases. A retrospective study and autopsy series. Arch Pathol Lab Med 125:880–887.

    PubMed  CAS  Google Scholar 

Literatur

  1. Agid Y (1998). Levodopa: is toxicity a myth? Neurology, 50:858–63.

    PubMed  CAS  Google Scholar 

  2. Baas H, Beiske AG, Ghika J, Jackson M, Oertel WH, Poewe W, Ransmayr G (1997). Catechol-Omethyltransferase inhibition with tolcapone reduces the „wearing off“ phenomenon and levodopa requirements in fluctuating parkinsonian patients. J Neurol Neurosurg Psychiatry, 63:421–8.

    Article  PubMed  CAS  Google Scholar 

  3. Bennett JJ, Landow ER, Schuh LA (1993). Suppression of dyskinesias in advanced Parkinson’s disease. II. Increasing daily clozapine doses suppress dyskinesias and improve parkinsonism symptoms. Neurology, 43:1551–1555.

    PubMed  Google Scholar 

  4. Bonnet AM, Serre I, Marconi R, Agid Y, Dubois B (1995). A „combined“ levodopa test as a useful method for evaluating the efficacy of dopamine agonists: application to pergolide and bromocriptine. Mov Disord, 10:668–71.

    Article  PubMed  CAS  Google Scholar 

  5. Carpentier AF, Bonnet AM, Vidailhet M, Agid Y (1996). Improvement of levodopa-induced dyskinesia by propranolol in Parkinson’s disease. Neurology, 46:1548–51.

    PubMed  CAS  Google Scholar 

  6. Ceballos-Baumann AO, Boecker H, Bartenstein P, von Falkenhayn I, Riescher H, Conrad B, Moringlane JR, Pinter M, Alesch F A. PET study of subthalamic nucleus stimulation in Parkinson’s disease: Enhanced movement related activity of motor association cortex and decreased motor cortex resting activity. Arch Neurol, in press.

    Google Scholar 

  7. Ceballos-Baumann AO, von Kummer R, Eckert W, Weicker H (1990). Controlled-release levodopa/benserazide (Madopar HBS): Clinical observations and levodopa and dopamine plasma concentrations in fluctuating parkinsonian patients. J Neurol, 237:24–28.

    Article  PubMed  CAS  Google Scholar 

  8. Durif F, Vidailhet M, Assal F, Roche C, Bonnet AM, Agid Y (1997). Low-dose clozapine improves dyskinesias in Parkinson’s disease. Neurology, 48:658–62.

    PubMed  CAS  Google Scholar 

  9. Durif F, Vidailhet M, Bonnet AM, Blin J, Agid Y (1995). Levodopa-induced dyskinesias are improved by fluoxetine. Neurology, 45:1855–8.

    PubMed  CAS  Google Scholar 

  10. Fahn S (1996). Is levodopa toxic? Neurology, 47:184–95.

    Google Scholar 

  11. Hughes AJ, Bishop S, Kleedorfer B, Turjanski N, Fernandez W, Lees AJ, Stern GM (1993). Subcutaneous apomorphine in Parkinson’s disease: response to chronic administration for up to five years. Mov Disord, 8:165–70.

    Article  PubMed  CAS  Google Scholar 

  12. Kornhuber J et al. (1989) Memantine displaces (3H) MK-801 at therapeutic concentrations in postmortem human frontal cortex. Europ J Pharmacol, 166:589–590.

    CAS  Google Scholar 

  13. Krack P, Pollak P, Limousin P, Hoffmann D, Xie J, Benazzouz A, Benabid AL (1998). Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson’s disease. Brain, 121:451–7.

    Article  PubMed  Google Scholar 

  14. Lieberman A, Olanow CW, Sethi K, Swanson P, Waters CH, Fahn S, Hurtig H, Yahr M (1998). A multicenter trial of ropinirole as adjunct treatment for Parkinson’s disease. Ropinirole Study Group. Neurology, 51:1057–62.

    PubMed  CAS  Google Scholar 

  15. Lieberman A, Ranhosky A, Korts D (1997). Clinical evaluation of pramipexole in advanced Parkinson’s disease: results of a double-blind, placebo-controlled, parallel-group study. Neurology, 49:162–8.

    PubMed  CAS  Google Scholar 

  16. Limousin P, Pollack P, Benazzouz A, Hoffmann D, Le Bas JF, Brousolle E, Perret JE, Benabid AL (1995). Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 345: 91–95.

    Article  PubMed  CAS  Google Scholar 

  17. Lozano AM, Lang AE, Galvez JN, Miyasaki J, Duff J, Hutchinson WD, Dostrovsky JO (1995). Effect of GPi pallidotomy on motor function in Parkinson’s disease [see comments]. Lancet, 346:1383–7.

    Article  PubMed  CAS  Google Scholar 

  18. Narabayashi H, Yokochi F, Nakajima Y (1984). Levodopa-induced dyskinesia and thalamotomy. J Neurol Neurosurg Psychiatry, 47:831–839.

    PubMed  CAS  Google Scholar 

  19. Poewe W, Ceballos-Baumann AO, Conrad B (1996). Parkinson-Krankheit. In: Bewegungsstörungen in der Neurologie. Edited by B. Conrad and A. O. Ceballos-Baumann. Thieme, Stuttgart pp. 30–60.

    Google Scholar 

  20. Pourcher E, Bonnet AM, Kefalos J, Dubois B, Agid Y (1989). Effects of etybenzatropine and diazepam on levodopa-induced diphasic dyskinesias in Parkinson’s disease. Mov Disord, 4:195–201.

    Article  PubMed  CAS  Google Scholar 

  21. Price P, Parkes JD, Marsden CD (1978). Tiaprid in Parkinson’s disease. Lancet, II, 1106.

    Google Scholar 

  22. Rinne UK, Larsen JP, Siden A, Worm-Petersen J (1998). Entacapone enhances the response to levodopa in parkinsonian patients with motor fluctuations. Nomecomt Study Group. Neurology, 51:1309–14.

    PubMed  CAS  Google Scholar 

  23. Siegfried J, Lippitz B (1994). Bilateral chronic electrostimulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all parkinsonian symptoms. Neurosurgery, 35:1126–1129.

    PubMed  CAS  Google Scholar 

  24. Verhagen Metman L, Del Dotto P, van den Munckhof P, Fang J, Mouradian MM, Chase TN (1998). Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson’s disease [see comments]. Neurology, 50:1323–6.

    PubMed  CAS  Google Scholar 

Literatur

  1. Burke RE, Kang UJ, Jankovic J, et al. (1989) Tardive akathisia: an analysis of clinical features and response to open therapeutic trials. Movement disorders 4:157–175

    PubMed  CAS  Google Scholar 

  2. Burke RE, Kang UJ (1988). Tardive dystonia: clinical aspects and treatment. Adv Neurol 49:199–210

    PubMed  CAS  Google Scholar 

  3. Burke RE, Reches A, Traub MM, et al. (1985) Tetrabenazine induces acute dystonic reactions. Ann Neurol; 17:200–2

    Article  PubMed  CAS  Google Scholar 

  4. Jankovic J, Orman J (1988) Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias. Neurology 38:391–394

    PubMed  CAS  Google Scholar 

  5. Kane JM, Smith JM (1982) Tardive dyskinesia. Arch Gen Psychiatry 39:473–481

    PubMed  CAS  Google Scholar 

  6. Lieberman JA, Saltz BL, Johns CA, et al. (1991) The effects of clozapine on tardive dyskinesia. Br J Psychiatry 158:503–10

    PubMed  CAS  Google Scholar 

  7. Miller LG, Jankovic J (1992). Drug induced movement disorders: an overview. In: Joseph AB and Young RP (eds). Movement disorders in neurology and psychiatry. Blackwell Scientific, Cambridge

    Google Scholar 

  8. Stacy M, Jankovic J (1992) Tardive tremor. Mov Disord 7:53–57

    Article  PubMed  CAS  Google Scholar 

  9. Thaker GK, Nguyen JA; Strauss ME, et al. (1990) Clonazepam treatment of tardive dyskinesia: a practical GABA mimetic strategy. Am J Psychiatry 147:445–51

    PubMed  CAS  Google Scholar 

Literatur

  1. Blitzer A, Brin MF, Greene PE, Fahn S (1989). Botulinum toxin injection for the treatment of oromandibular dystonia. Ann Otol Rhinol Laryngol 98: 93–7.

    PubMed  CAS  Google Scholar 

  2. Blitzer A, Brin MF, Stewart C et al. (1992) Abductor laryngeal dystonia: a series treated with botulinum toxin. Laryngoscope 102: 163–7.

    PubMed  CAS  Google Scholar 

  3. Blitzer A, Brin MF (1991). Laryngeal dystonia: a series with botulinum toxin therapy. Ann Otol Rhinol Laryngol 100: 85–9.

    PubMed  CAS  Google Scholar 

  4. Ceballos-Baumann AO, Böhme G, Konstanzer A et al. (1992) Spasmodische Dysphonie: Klinik und Erfahrungen mit laryngealen Injektionen von Botulinum-Toxin. Otorhinolaryngologia nova 2: 33–38.

    Google Scholar 

  5. Marion MH, Klap P, Perrin A, Cohen M (1992). Stridor and focal laryngeal dystonia. Lancet 339:457–8.

    Article  PubMed  CAS  Google Scholar 

  6. Riski JE, Horner J, Nashold BJ (1990). Swallowing function in patients with spasmodic torticollis. Neurology 40: 1443–5.

    PubMed  CAS  Google Scholar 

Literatur

  1. Braun V, Richter HP (1991). Selective peripheral denervation in patients with spasmodic torticollis. Stereotact Funct Neurosurg 57: 113–22.

    PubMed  CAS  Google Scholar 

  2. Burke RE, Fahn S, Marsden CD (1986). Torsion dystonia: a double-blind, prospective trial of highdosage trihexyphenidyl. Neurology 36(2): 160–4.

    PubMed  CAS  Google Scholar 

  3. Ceballos-Baumann AO, Kupsch A, Naumann M, Volkmann J (2002). Dystonie. In: Leitlinien der deutschen Gesellschaft für Neurologie, http://www.dgn.org/leitl.shtml.

    Google Scholar 

  4. Ceballos-Baumann AO (2001). Evidence-based medicine in botulinum toxin therapy for cervical dystonia. J Neurol 248Suppl 1: 14–20.

    PubMed  Google Scholar 

  5. Coubes P, Roubertie A, Vayssiere N, Hemm S, Echenne B (2000). Treatment of DYT1-generalised dystonia by stimulation of the internal globus pallidus. Lancat 355(9222): 2220–1.

    CAS  Google Scholar 

  6. Fahn S, Bressman SB, Marsden CD (1998). Classification of dystonia. Adv Neurol 78: 1–10.

    PubMed  CAS  Google Scholar 

  7. Manji H, Howard RS, Miller DH, Hirsch NP, Carr L, Bahtia K, Quinn N, Marsden CD (1998). Status dystonicus: the syndrome and ist management. Brain 121 (Pt 2): 243–52.

    Article  PubMed  Google Scholar 

  8. Nemeth AH (2002). The genetics of primary dystonias and related disorders. Brain 125 (Pt 4): 695–721.

    Article  PubMed  Google Scholar 

  9. Speelman D, v. M. J (1989). Cerebral palsy and stereotactic neurosurgery: long term results. J Neurol Neurosurg Psychiatry 52(1): 23–30.

    PubMed  CAS  Google Scholar 

  10. van Hilten BJ, van de Beek WJ, Hoff JI, Voormolen JH, Delhaas EM (200). Intrathecal baclofen for the treatment of dystonia inpatients with reflex sympathetic dystrophy. N Engl J Med 343(9): 625–30.

    Google Scholar 

  11. Walker RH, Danisi FO, Swope DM, Goodman RR, Germano IM, Brin MF (2000). Intrathecal baclofen for dystoia: benefits and complications during six years of experience. Mov Disord 15(6): 1242–7.

    Article  PubMed  CAS  Google Scholar 

Literatur

  1. Fahn S, Bressman SB, Marsden CD (1998). Classification of dystonia. Adv. Neurol 78: 1–10.

    PubMed  CAS  Google Scholar 

  2. Nemeth AH (2002). The genetics of primary dystonias and related disorders. Brain 125 (Pt 4): 695–721.

    Article  PubMed  Google Scholar 

Literatur

  1. Zimprich A, Grabowski M, Asmus F, Naumann M, Berg D, Bertram M, Scheidtmann K, Kern P, Winkelmann J, Muller Myhsok B, Riedel L, Bauer M, Muller T, Castro M, Meitinger T, Strom TM, Gasser T (2001). Mutations in the gene encoding epsilon-sarcoglycan cause myoclonusdystonia syndrome. Nat Genet 29(1): 66–9.

    Article  PubMed  CAS  Google Scholar 

Literatur

  1. Angelini L, Rumi V, Lamperti E, Nardocci N (1988). Transient paroxysmal dystonia in infancy. Neuropediatrics 19(4): 171–4.

    Article  PubMed  CAS  Google Scholar 

  2. Bhatia KP (1999). The paroxysmal dyskinesias. J Neurol 246(3): 149–55.

    Article  PubMed  CAS  Google Scholar 

Literatur

  • Walshe JM, Yealland M (1992). Wilson’s disease: the problem of delayed diagnosis. J Neurol Neurosurg Psychiatry 55: 692–6.

    PubMed  CAS  Google Scholar 

Literatur

  1. Fahn S, Bressman SB, Marsden CD (1998). Classification of dystonia. Adv Neurol 78: 1–10.

    PubMed  CAS  Google Scholar 

Download references

Editor information

Editors and Affiliations

  1. Klinik für Neurologie mit Klinischer Neurophysiologie, Alfried-Krupp-Krankenhaus, Alfried-Krupp-Straße 21, 45131, Essen

    Peter Berlit

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

(2005). D. In: Berlit, P. (eds) Therapielexikon Neurologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26367-5_4

Download citation

  • DOI: https://doi.org/10.1007/3-540-26367-5_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-67137-4

  • Online ISBN: 978-3-540-26367-8

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation